Drugs / 3,4-Methylenedioxyamphetamine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04847206 | Dec 2021 → Jun 2024 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 3,4-Methylenedioxyamphetamine | “3,4-Methylenedioxyamphetamine (MDA) is a psychoactive metabolite of MDMA.” PMID 40999236 ↗ Sep 2025 |
| Modality | Small molecule | “3,4-Methylenedioxyamphetamine (MDA) is a psychoactive metabolite of MDMA.” PMID 40999236 ↗ Sep 2025 |